Soluble and Tissue Biomarkers in Ankylosing Spondylitis
- 31 October 2010
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Rheumatology
- Vol. 24 (5), 671-682
- https://doi.org/10.1016/j.berh.2010.05.009
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Tools for monitoring spondyloarthritis in clinical practiceNature Reviews Rheumatology, 2009
- Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 CriteriaThe Journal of Rheumatology, 2009
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selectionAnnals Of The Rheumatic Diseases, 2009
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisalAnnals Of The Rheumatic Diseases, 2009
- ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2008
- Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three‐month, randomized, placebo‐controlled trialArthritis & Rheumatism, 2003
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- An approach to the validation of markers for use in AIDS clinical trials.Clinical Infectious Diseases, 1997
- The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of SpondylarthropathyArthritis & Rheumatism, 1991
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984